Temporal patterns of lipid testing and statin therapy in acute coronary syndrome patients (from the Canadian GRACE experience)

American Journal of Cardiology

Volumn 109, Issue 10, 2012, Pages 1418-1424

  Elbarouni, Basem ^a,b   Banihashemi, S Behnam ^a,b   Yan, Raymond T ^b   Welsh, Robert C ^d   Kornder, Jan M ^e   Wong, Graham C ^f   Anderson, Frederick A ^g   Spencer, Frederick A ^h   Grondin, François R ⁱ   Goodman, Shaun G ^a,b,c   Yan, Andrew T ^a,b,c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c CANADIAN HEART RESEARCH CENTRE   (Canada)

^d MAZANKOWSKI ALBERTA HEART INSTITUTE   (Canada)

^e SURREY MEMORIAL HOSPITAL   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g UNIVERSITY OF MASSACHUSETTS   (United States)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ Hotel Dieu de Levis Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CANADA; DIET RESTRICTION; FEMALE; GLOBAL REGISTRY OF ACUTE CORONARY EVENTS SCORE; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTICENTER STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM;

EID: 84860489355     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.01.352     Document Type: Article

References (25)

1. D.T. Ko, D.A. Alter, A.M. Newman, L.R. Donovan, J.V. Tu Association between lipid testing and statin therapy in acute myocardial infarction patients Am Heart J 150 2005 419 425
2. J.M. Foody, M.T. Roe, A.Y. Chen, S.C. Smith Jr., R.G. Brindis, E.D. Peterson, W.B. Gibler, E.M. Ohman CRUSADE Investigators Lipid management in patients with unstable angina pectoris and non-ST-segment elevation acute myocardial infarction (from CRUSADE) Am J Cardiol 95 2005 483 485
3. J.N. Rasmussen, G.H. Gislason, S.Z. Abildstrom, S. Rasmussen, I. Gustafsson, P. Buch, J. Friberg, L. Kober, C. Torp-Pedersen, M. Madsen, S. Stender Statin use after acute myocardial infarction: a nationwide study in Denmark Br J Clin Pharmacol 60 2005 150 158
4. G.C. Fonarow, W.J. French, P.D. Frederick Trends in the use of lipid-lowering medications at discharge in patients with acute myocardial infarction: 1998 to 2006 Am Heart J 157 2009 185 194
5. A.T. Yan, R.T. Yan, M. Tan, T. Huynh, K. Soghrati, L.J. Brunner, P. DeYoung, D.H. Fitchett, A. Langer, S.G. Goodman Canadian ACS Registries Investigators Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome Am Heart J 154 2007 1108 1115
6. GRACE Investigators Rationale and design of the GRACE (Global Registry of Acute Coronary Events) project: a multinational registry of patients hospitalized with acute coronary syndromes Am Heart J 141 2001 190 199
7. S.G. Goodman, W. Huang, A.T. Yan, A. Budaj, B.M. Kennelly, J.M. Gore, K.A. Fox, R.J. Goldberg, F.A. Anderson Jr Expanded Global Registry of Acute Coronary Events (GRACE2) Investigators The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes Am Heart J 158 2009 193 201
8. C.P. Cannon, E. Braunwald, C.H. McCabe, D.J. Rader, J.L. Rouleau, R. Belder, S.V. Joyal, K.A. Hill, M.A. Pfeffer, A.M. Skene Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22 Investigators Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504
9. J.A. de Lemos, M.A. Blazing, S.D. Wiviott, E.F. Lewis, K.A. Fox, H.D. White, J.L. Rouleau, T.R. Pedersen, L.H. Gardner, R. Mukherjee, K.E. Ramsey, J. Palmisano, D.W. Bilheimer, M.A. Pfeffer, R.M. Califf, E. Braunwald A to Z Investigators Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial JAMA 292 2004 1307 1316
10. G.G. Schwartz, A.G. Olsson, M.D. Ezekowitz, P. Ganz, M.F. Oliver, D. Waters, A. Zeiher, B.R. Chaitman, S. Leslie, T. Stern Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial JAMA 285 2001 1711 1718
11. S.M. Grundy, J.I. Cleeman, C.N. Merz, H.B. Brewer Jr, L.T. Clark, D.B. Hunninghake, R.C. Pasternak, S.C. Smith Jr, N.J. Stone National Heart, Lung, and Blood Institute, American College of Cardiology Foundation, American Heart Association Implications of recent clinical trials for the National Cholesterol Education Program adult treatment Panel III guidelines Circulation 110 2004 227 239
12. R.S. Wright, J.L. Anderson, C.D. Adams, C.R. Bridges, D.E. Casey Jr, S.M. Ettinger, F.M. Fesmire, T.G. Ganiats, H. Jneid, A.M. Lincoff, E.D. Peterson, G.J. Philippides, P. Theroux, N.K. Wenger, J.P. Zidar, E.M. Antman, R.M. Califf, W.E. Chavey II, J.S. Hochman, T.N. Levin 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons J Am Coll Cardiol 57 suppl 2011 e215 e367
13. E.M. Antman, M. Hand, P.W. Armstrong, E.R. Bates, L.A. Green, L.K. Halasyamani, J.S. Hochman, H.M. Krumholz, G.A. Lamas, C.J. Mullany, D.L. Pearle, M.A. Sloan, S.C. Smith Jr, D.T. Anbe, F.G. Kushner, J.P. Ornato, A.K. Jacobs, C.D. Adams, J.L. Anderson, C.E. Buller, M.A. Creager, S.M. Ettinger, J.L. Halperin, S.A. Hunt, B.W. Lytle, R. Nishimura, R.L. Page, B. Riegel, L.G. Tarkington, C.W. Yancy Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 Writing Committee Circulation 117 2008 296 329
14. T.J. Ryan, E.M. Antman, N.H. Brooks, R.M. Califf, L.D. Hillis, L.F. Hiratzka, E. Rapaport, B. Riegel, R.O. Russell, E.E. Smith III, W.D. Weaver, R.J. Gibbons, J.S. Alpert, K.A. Eagle, T.J. Gardner, A. Garson Jr, G. Gregoratos, S.C. Smith Jr Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) J Am Coll Cardiol 34 1999 890 911
15. F.M. Sacks, M.A. Pfeffer, L.A. Moye, J.L. Rouleau, J.D. Rutherford, T.G. Cole, L. Brown, J.W. Warnica, J.M. Arnold, C.C. Wun, B.R. Davis, E. Braunwald The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels Cholesterol and Recurrent Events Trial investigators N Engl J Med 335 1996 1001 1009
16. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S) Lancet 345 1995 1274 1275
17. S.D. Wiviott, C.P. Cannon, D.A. Morrow, K.K. Ray, M.A. Pfeffer, E. Braunwald PROVE IT-TIMI 22 Investigators Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy J Am Coll Cardiol 46 2005 1411 1416
18. A.T. Yan, R.T. Yan, M. Tan, D.G. Hackam, K.L. Leblanc, H. Kertland, J.L. Tsang, S. Jaffer, M.L. Kates, L.A. Leiter, D.H. Fitchett, A. Langer, S.G. Goodman Vascular Protection (VP) and Guidelines Oriented Approach to Lipid Lowering (GOALL) Registries Investigators Contemporary management of dyslipidemia in high-risk patients: targets still not met Am J Med 119 2006 676 683
19. D.D. Waters, C. Brotons, C.W. Chiang, J. Ferrières, J. Foody, J.W. Jukema, R.D. Santos, J. Verdejo, M. Messig, R. McPherson, K.B. Seung, L. Tarasenko Lipid Treatment Assessment Project 2 Investigators Lipid Treatment Assessment Project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals Circulation 120 2009 28 34
20. R.P. Morrissey, G.A. Diamond, S. Kaul Statins in acute coronary syndromes: do the guideline recommendations match the evidence? J Am Coll Cardiol 54 2009 1425 1433
21. J. Genest, R. McPherson, J. Frohlich, T. Anderson, N. Campbell, A. Carpentier, P. Couture, R. Dufour, G. Fodor, G.A. Francis, S. Grover, M. Gupta, R.A. Hegele, D.C. Lau, L. Leiter, G.F. Lewis, E. Lonn, G.B. Mancini, D. Ng, G.J. Pearson, A. Sniderman, J.A. Stone, E. Ur 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult -2009 recommendations Can J Cardiol 25 2009 567 579
22. H.D. Aronow, G.M. Novaro, M.S. Lauer, D.M. Brennan, A.M. Lincoff, E.J. Topol, D.J. Kereiakes, S.E. Nissen In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysis Arch Intern Med 163 2003 2576 2582
23. A.T. Yan, R.T. Yan, M. Tan, A. Fung, E.A. Cohen, D.H. Fitchett, A. Langer, S.G. Goodman Canadian Acute Coronary Syndromes 1 and 2 Registry Investigators Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromes Arch Intern Med 167 2007 1009 1016
24. D.T. Ko, M. Mamdani, D.A. Alter Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox JAMA 291 2004 1864 1870
25. C.J. Santolin, L.S. Boyer Change of care for patients with acute myocardial infarctions through algorithm and standardized physician order sets Crit Pathw Cardiol 3 2004 79 82